PUBLISHER: The Business Research Company | PRODUCT CODE: 1942646
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942646
A deep brain stimulation (DBS) system is a medical device that employs implanted electrodes to deliver controlled electrical pulses to specific areas of the brain. This technology is utilized to regulate abnormal brain activity and alleviate symptoms associated with various neurological conditions.
The primary products within the realm of deep brain stimulation systems are single-channel and dual-channel systems. Single-channel systems involve devices designed for applying targeted electrical or magnetic stimulation to specific brain regions. These systems find applications across various medical conditions, including Parkinson's disease, essential tremor, obsessive-compulsive disorder, epilepsy, dystonia, and others. These systems are employed by diverse end-users such as hospitals, ambulatory surgical centers, neurological clinics, and other healthcare facilities.
Tariffs are impacting the deep brain stimulation systems market by increasing costs of imported microelectronics, implantable electrodes, pulse generators, and precision manufacturing components. Hospitals and neurological centers in North America and Europe are most affected due to reliance on globally sourced medical device components, while Asia-Pacific faces pricing pressure on device imports. These tariffs are contributing to higher procedural costs and extended procurement cycles. However, they are also encouraging localized manufacturing, regional supply chain diversification, and investment in domestic production of advanced neuromodulation systems.
The deep brain stimulation systems market research report is one of a series of new reports from The Business Research Company that provides deep brain stimulation systems market statistics, including deep brain stimulation systems industry global market size, regional shares, competitors with a deep brain stimulation systems market share, detailed deep brain stimulation systems market segments, market trends and opportunities, and any further data you may need to thrive in the deep brain stimulation systems industry. This deep brain stimulation systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The deep brain stimulation systems market size has grown rapidly in recent years. It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growing prevalence of neurological disorders, increasing clinical acceptance of neuromodulation therapies, advancements in implantable medical device technology, expansion of neurology specialty centers, improved long-term patient outcomes.
The deep brain stimulation systems market size is expected to see rapid growth in the next few years. It will grow to $4.52 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing investments in next-generation neurostimulation devices, rising demand for personalized neurological treatments, expansion of dbs indications beyond movement disorders, growing integration of ai-driven programming, increasing focus on remote patient monitoring. Major trends in the forecast period include increasing adoption of adaptive dbs systems, rising use of image-guided electrode placement, growing demand for rechargeable neurostimulators, expansion of personalized neuromodulation therapies, enhanced focus on minimally invasive implantation techniques.
The rising prevalence of neurological disorders is expected to drive the growth of the deep brain stimulation systems market in the coming years. Neurological disorders encompass a diverse group of diseases that affect the body's autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are utilized in neurosurgical procedures to deliver electrical impulses to targeted brain regions, with the goal of modifying or regulating neural activity and achieving a reversible, adjustable, and therapeutic outcome. For example, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population is currently affected by some form of neurological condition, and this burden is projected to nearly double by 2050. Consequently, the increasing prevalence of neurological disorders is contributing to the growth of the deep brain stimulation systems market.
Key players within the deep brain stimulation systems market are actively engaged in pioneering innovative technologies, such as deep brain stimulation (DBS) systems, to cater to patients with movement disorders. DBS entails a medical procedure involving the implantation of a device that administers electrical currents directly to specific brain regions. For instance, in January 2024, Abbott Laboratories, a US-based medical devices and healthcare company, unveiled the Liberta RC DBS system-a groundbreaking rechargeable deep brain stimulation device with remote programming capabilities, deemed the world's smallest in its category. The Liberta RC DBS system represents a pioneering advancement in connected care technology, allowing patients to maintain communication with their healthcare providers, ensure optimal device configuration and operation, and receive updated treatment settings remotely as needed, eliminating the necessity for in-person visits to medical facilities.
In October 2025, Medtronic plc, a US-based medical device company offering a comprehensive range of deep brain stimulation (DBS) technologies and technical support, entered into a partnership with Siemens Healthineers for an undisclosed amount. This collaboration is intended to integrate advanced imaging capabilities into Medtronic's AiBLE ecosystem, which includes surgical navigation and robotic platforms, thereby improving the accuracy of electrode placement in neurosurgical procedures, including DBS used to treat movement disorders such as Parkinson's disease. Siemens Healthineers is a Germany-based medical technology company.
Major companies operating in the deep brain stimulation systems market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Beijing PINS Medical Co Ltd, SceneRay Corporation Ltd, NeuroPace Inc, LivaNova PLC, NeuroSigma Inc, Functional Neuromodulation Ltd, Synapse Biomedical Inc, Soterix Medical Inc, FHC Inc, Newronika S.p.A, Renishaw plc, Deep Brain Innovations LLC, BlueWind Medical Ltd, Magstim Company Ltd, Sapiens Steering Brain Stimulation, Bioinduction Ltd, Alpha Omega Engineering
North America was the largest region in the deep brain stimulation systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deep brain stimulation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the deep brain stimulation systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The deep brain stimulation system market includes revenues earned by entities by providing services such as electrode implantation, pulse generator implantation, surgical implantation services, diagnostic and preoperative services, programming and adjustment services, patient education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The deep brain stimulation system market also includes of sales of extension wires, remote controls, and electrodes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Deep Brain Stimulation Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses deep brain stimulation systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for deep brain stimulation systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deep brain stimulation systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.